The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHG.L Regulatory News (GHG)

  • There is currently no data for GHG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - GEORGIA HEALTHCARE GROUP PLC

18 May 2020 12:09

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: COELI FRONTIER MARKETS AB
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

OFFEROR: Georgia Capital plc, GB00BF4HYV08
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

2020-05-13
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

OFFEREE: Georgia Healthcare Group plc, GB00BYSS4K11

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 1p ordinary

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 646 152 1,609
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

646 152 1,609

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit
1p ordinary Sale 7904 4,331

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 2020-05-18
Contact name: Joakim Lundmark
Telephone number*: +46 (0)709379752

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200518005359/en/

Copyright Business Wire 2020

Date   Source Headline
25th Oct 20177:00 amRNSGHG launches a new Polyclinic cluster
23rd Oct 20177:00 amRNSPharma business acquires private label brand
16th Oct 201712:07 pmRNSSecond Price Monitoring Extn
16th Oct 201712:02 pmRNSPrice Monitoring Extension
29th Sep 20177:00 amRNSGHG Investor Day Notice
23rd Aug 20177:00 amRNSGHG will hold Investor Day on 10 November
15th Aug 20177:00 amRNSHalf-year Report
11th Aug 20178:14 amRNSHolding(s) in Company
11th Aug 20177:00 amRNSNotice of Results
24th Jul 20177:00 amRNSThe acquisition of two community hospitals
17th Jul 20177:00 amRNSIssuance of bonds by healthcare services business
14th Jul 20174:40 pmRNSSecond Price Monitoring Extn
14th Jul 20174:35 pmRNSPrice Monitoring Extension
13th Jul 20174:40 pmRNSSecond Price Monitoring Extn
13th Jul 20174:35 pmRNSPrice Monitoring Extension
5th Jul 201712:02 pmRNSPrice Monitoring Extension
3rd Jul 20174:35 pmRNSPrice Monitoring Extension
29th Jun 20174:06 pmRNSDirector/PDMR Shareholding
28th Jun 20177:53 amRNSDirector/PDMR Shareholding
21st Jun 20177:00 amRNSDirectorate Change
15th Jun 20174:35 pmRNSPrice Monitoring Extension
12th Jun 201711:47 amRNSDirector/PDMR Shareholding
1st Jun 20173:43 pmRNSResult of AGM
30th May 20177:00 amRNSGHG AGM Update
24th May 20177:00 amRNSDirector/PDMR Shareholding
8th May 20177:00 amRNS1st Quarter Results
4th May 201711:13 amRNSNotice of Results
2nd May 20177:09 amRNSNotice of AGM
13th Apr 20177:00 amRNSAnnual Financial Report
11th Apr 20175:46 pmRNSDirector/PDMR Shareholding
3rd Apr 20177:00 amRNSGHG announces opening of "Sunstone"
31st Mar 20174:40 pmRNSSecond Price Monitoring Extn
31st Mar 20174:35 pmRNSPrice Monitoring Extension
28th Mar 20174:35 pmRNSPrice Monitoring Extension
27th Mar 20177:54 amRNSGHG announces two Group management appointments
21st Mar 20177:00 amRNSDirector/PDMR Shareholding
20th Mar 20177:00 amRNSABC former shareholders purchase GHG shares
7th Mar 20177:00 amRNSDirector/PDMR Shareholding
28th Feb 20179:58 amRNSDirector/PDMR Shareholding
24th Feb 20173:03 pmRNSDirector/PDMR Shareholding
15th Feb 20177:00 amRNSFinal Results
13th Feb 20177:00 amRNSNotice of Results
6th Jan 20177:00 amRNSGHG announces completion of the acquisition of ABC
30th Dec 20167:00 amRNSGHG launches a new ambulatory cluster in Tbilisi
28th Dec 20167:00 amRNSGHG launches a new ambulatory cluster
1st Dec 20163:09 pmRNSDirector/PDMR Shareholding
23rd Nov 20167:00 amRNSGHG hosts Investor Day in Tbilisi
21st Nov 20167:37 amRNS3rd Quarter Results
21st Nov 20167:00 amRNSAcquisition
18th Nov 20167:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.